Here's How Many Biotech Stocks Have Blown Up Each Year Since 1990

Investing in biotech can be risky.

Small, publicly-traded companies, the fortunes of which are often tied to the success of a single drug in making it out of trial phases, are often prone to big price swings.

In a note to clients, ISI analyst Mark Schoenebaum highlights a chart of the number of biotech stock “blow-ups” each year since 1990.

“For purposes of this analysis, we have defined a ‘blow up’ as a one day downward stock move of 25% or more. We have defined ‘biotech’ as those biotech companies listed in the S&P 1500 and/or the Russell 3000 in any given year,” writes Schoenebaum. “If you look at the trend, it doesn’t look scary to me . . . . what do you think?”

NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at research.businessinsider.com.au.